China Universal Asset Management »

Aclaris Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.0k 8.2k 1.10
2023-09-30 $12k 1.8k 6.62
2023-06-30 $10k 926 10.80
2023-03-31 $7.0k 903 7.75
2022-12-31 $11k 678 16.22
2022-09-30 $10k 624 16.03

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Vertex Pharmaceuticals Common Stock (VRTX)
Adobe Common Stock (ADBE)
Nvidia Corp Common Stock (NVDA)
Meta Platforms Inc-class A Common Stock (META)
Servicenow Common Stock (NOW)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Gilead Sciences Common Stock (GILD)
Tesla Common Stock (TSLA)
Visa Inc-class A Shares Common Stock (V)
Workday Inc-class A Common Stock (WDAY)
Alphabet Inc-cl A Common Stock (GOOGL)
Salesforce Common Stock (CRM)

View all positions for China Universal Asset Management

Top funds holding Aclaris Therapeutics

BML Capital Management
Citadel Advisors
Vanguard Group
Millennium Management
D. E. Shaw & Co
Tang Capital Management
GSA Capital Partners
Two Sigma Investments
Two Sigma Advisers
Monaco Asset Management SAM
Deutsche Bank Aktiengesellschaft
Jacobs Levy Equity Management
Samsara BioCapital
Goldman Sachs Group
Citigroup

View all funds holding Aclaris Therapeutics